Pharmacological Inhibition of HDAC6 Attenuates NLRP3 Inflammatory Response and Protects Dopaminergic Neurons in Experimental Models of Parkinson’s Disease

Overview of attention for article published in Frontiers in Aging Neuroscience, March 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 43 Dimensions

Readers on

mendeley: 55 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 89,257 followers.

RT @ScienceofPD: Chinese researchers report pharmacological inhibition of HDAC6 by tubastatin A - a selective HDAC6 inhibitor - attenuates…

24 Apr 2020

Reply Repost Favourite

Chinese researchers report pharmacological inhibition of HDAC6 by tubastatin A - a selective HDAC6 inhibitor - attenuates NLRP3 inflammatory response & protects dopamine neurons (possibly via Prx2 acetylation) in models of #Parkinsons https://t.co/2cc8

17 Apr 2020

Reply Repost Favourite

RT @FrontNeurosci: New Research: Pharmacological Inhibition of HDAC6 Attenuates NLRP3 Inflammatory Response and Protects Dopaminergic Neuro…

13 Apr 2020

Reply Repost Favourite

RT @FrontNeurosci: New Research: Pharmacological Inhibition of HDAC6 Attenuates NLRP3 Inflammatory Response and Protects Dopaminergic Neuro…

13 Apr 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.